Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine as adjunct sedation in TBI
NCT05097261Phase 4Recruiting
- Start
- Sep 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in traumatic brain injury (TBI). Started Sep 2021; status: recruiting.
02
Drugs
ketamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05097261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05097261.